News
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...
The World Health Organization estimates that approximately 2.2 billion cases have been prevented between 2000 and 2023.
In this week's Texas Border Watch, exchange houses are facing a battle, the DoD gives insight into military border operations ...
You have this convergence of crises,” says Dr. Angelle Desiree LaBeaud. Here’s what that means and how she and others are ...
Éducation Plus on MSN15d
Velocity vector modulusDiscover how to calculate the modulus (magnitude) of a velocity vector! This tutorial explains how to find the speed of an ...
A newly published study in the Journal of Medical Entomology provides critical insights into the emergence of babesiosis in ...
Crackdown' highlights how drug policy has shaped the toxic drug crisis and what can be done about it. A Tyee Q&A.
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...
This expanded offering supports standardized, high-precision quality control (QC) workflows and strengthens the position of QIAGEN as a trusted partner for quality control, supporting biotech and ...
Nigeria, Kebbi and Yobe stand out in Nigeria for their high malaria prevalence, each facing unique challenges in their fight against the disease.
Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results